Hospira Logo (Cytarabine 01)
Cytarabine Injection, Solution
Product Images NDC 61703-304
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cytarabine (NDC 61703-304). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Structural Formula Cytarabine Injection (Cytarabine 02)
Hospira Logo (Cytarabine 03)
Principal Display Panel (25 mL Vial Label)
Principal Display Panel (25 mL Vial Carton)
Cytarabine Injection is a medication used for intravenous or subcutaneous purposes containing 20mg Gytarabine, USP in 1mL with inactive ingredients such as benzyl alcohol 0.9% and water for injection. It is advised that the package insert is read for complete prescribing and product information before administering. This is not recommended to be used for intrathecal or high dose investigational use and it should be protected from light. It is stored between 20°C to 25°C (68°F to 77°F) in a sterile muti-dose vial until used. This drug is distributed by Hospira, Inc, located in Lake Forest, IL, USA.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
